WoodTrust Financial’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,750
Closed -$1.17M 151
2022
Q3
$1.17M Buy
4,750
+250
+6% +$67.5K 0.26% 62
2022
Q2
$1.11M Buy
4,500
+615
+16% +$166K 0.25% 64
2022
Q1
$1.29M Buy
3,885
+200
+5% +$61.6K 0.26% 62
2021
Q4
$1.32M Buy
3,685
+810
+28% +$274K 0.27% 52
2021
Q3
$936K Buy
2,875
+1,725
+150% +$584K 0.22% 55
2021
Q2
$359K Buy
1,150
+375
+48% +$115K 0.09% 84
2021
Q1
$247K Sell
775
-330
-30% -$106K 0.07% 81
2020
Q4
$358K Sell
1,105
-75
-6% -$20.7K 0.11% 63
2020
Q3
$327K Sell
1,180
-150
-11% -$43.2K 0.12% 68
2020
Q2
$321K Buy
+1,330
New +$267K 0.13% 60

Other funds holding ABMD

WoodTrust Financial's ABMD Position: Q4 2022 in Review

WoodTrust Financial sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4,750 shares — an estimated $1.17M sold.

WoodTrust Financial first reported a position in ABMD in Q2 2020 and held it in 10 quarters. The position peaked at $1.32M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • WoodTrust Financial reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • WoodTrust Financial sold 4,750 Abiomed Inc shares in Q4 2022, an estimated $1.17M.
  • WoodTrust Financial first reported a position in Abiomed Inc in Q2 2020 and held it in 10 quarters.
  • WoodTrust Financial's Abiomed Inc position peaked at $1.32M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on WoodTrust Financial's 13F filing for Q4 2022, filed 23 Jan 2023.